Englander Institute for Precision Medicine

Publications

Found 695 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Gajic ZZ, Deshpande A, Legut M, Imielinski M, Sanjana NE.  2022.  Recurrent somatic mutations as predictors of immunotherapy response.. Nat Commun. 13(1):3938.
Galassi C, Ruan Y, Sato A, Jiménez-Cortegana C, Klapp V, Bloy N, Guilbaud E, Petroni G, Buqué A, Galluzzi L et al..  2022.  RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells.. Methods Cell Biol. 172:145-161.
Galassi C, Galluzzi L.  2023.  Cancer stem cell immunoediting by IFNγ.. Cell Death Dis. 14(8):538.
Galassi C, Galluzzi L.  2023.  Epigenetic escape of immunosurveillance by malignant cell precursors.. EMBO J. 42(10):e114050.
Galassi C, Klapp V, Yamazaki T, Galluzzi L.  2024.  Molecular determinants of immunogenic cell death elicited by radiation therapy.. Immunol Rev. 321(1):20-32.
Galassi C, Vitale I, Galluzzi L.  2021.  Using epigenetic modifiers to target cancer stem cell immunoevasion.. Cancer Cell. 39(12):1573-1575.
Galassi C, Klapp V, Formenti SC, Demaria S, Galluzzi L.  2023.  Immunologically relevant effects of radiation therapy on the tumor microenvironment.. Essays Biochem.
Galluzzi L, Kroemer G.  2020.  Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? Trends Cell Biol. 30(5):339-340.
Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G.  2020.  Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.. Nat Rev Clin Oncol. 17(12):725-741.
Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM.  2023.  Immunogenic cell death in cancer: concept and therapeutic implications.. J Transl Med. 21(1):162.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez ABuqué, Chan TA, Coukos G, Demaria S, Deutsch E et al..  2020.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.. J Immunother Cancer. 8(1)
Galluzzi L, Petroni G, Kroemer G.  2020.  Immunogenicity of cell death driven by immune effectors.. J Immunother Cancer. 8(1)
Galluzzi L, Myint M.  2023.  Cell death and senescence.. J Transl Med. 21(1):425.
Galluzzi L, Garg AD.  2021.  Immunology of Cell Death in Cancer Immunotherapy.. Cells. 10(5)
Galluzzi L, Aryankalayil MJ, C Coleman N, Formenti SC.  2023.  Emerging evidence for adapting radiotherapy to immunotherapy.. Nat Rev Clin Oncol.
Galluzzi L.  2020.  Targeting Mutant KRAS for Immunogenic Cell Death Induction.. Trends Pharmacol Sci. 41(1):1-3.
Galluzzi L, Kroemer G.  2022.  Calreticulin surface presentation can promote quality control of hematopoietic stem cells.. Trends Immunol. 43(12):950-952.
Ganly I, Liu EMinwei, Kuo F, Makarov V, Dong Y, Park J, Gong Y, Gorelick AN, Knauf JA, Benedetti E et al..  2022.  Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.. Sci Adv. 8(25):eabn9699.
Gao VR, Yang R, Das A, Luo R, Luo H, McNally DR, Karagiannidis I, Rivas MA, Wang Z-M, Barisic D et al..  2023.  ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.. bioRxiv.
Gayvert K, Elemento O.  2019.  Drug-Induced Expression-Based Computational Repurposing of Small Molecules Affecting Transcription Factor Activity.. Methods Mol Biol. 1903:179-184.